High mechanical conditioning by tumor extracellular matrix stiffness is a predictive biomarker for anti-fibrotic therapy in HER2-negative breast cancer.
Quintela-Fandino M, Bermejo B, Zamora E, Moreno F, Garcia-Saenz JÁ, Pernas S, Martinez Jañez N, Jiménez D, Adrover E, Andrés R, Mourón S, Bueno MJ, Manso L, Viñas G, Alba E, Llombart-Cussac A, Cortes J, Tebar C, Roe DJ, Grant A, Watson A, Colomer R, Mouneimne G.
Quintela-Fandino M, et al. Among authors: watson a.
Clin Cancer Res. 2024 Sep 16. doi: 10.1158/1078-0432.CCR-24-1518. Online ahead of print.
Clin Cancer Res. 2024.
PMID: 39283720